Influence of the ACE gene I/D polymorphism on insulin sensitivity and impaired glucose tolerance in healthy subjects

Abstract

Objective: Recent studies suggested that the blockade of the renin-angiotensin system (RAS) may be associated with metabolic benefits. However, data about the potential influence of the ACE I/D genotype on insulin resistance have been contradictory with studies of limited sample sizes. The purpose of this study was to investigate the relationship between the ACE gene I/D polymorphism and both insulin sensitivity and glucose intolerance in a large cohort of healthy subjects.

Research design and methods: 1286 participants in the RISC study had a 75-g oral glucose tolerance test and a hyperinsulinemic-euglycemic clamp to assess whole body insulin sensitivity.

Results: Age, BMI, waist, fat-free mass and physical activity did not differ by ACE genotype. Fasting glucose and insulin were similar among genotypes, but 2h glucose levels were higher in DD than in ID and II subjects (DD: 5.9±1.7; ID: 5.7±1.5; II: 5.6±1.5 mmol/l, p=0.004). Participants with the DD genotype were more likely to have impaired glucose tolerance than those with the ID and II genotypes (13.1% vs 8.7%, p=0.02).

Results: Insulin sensitivity was lower in participants with the DD genotype than in those with the II genotype (136 ±63 vs 147 ±65 μmol.min^-1.kgffm^-1.mM^-1, p=0.02). The presence of the D allele was associated with a trend, albeit not significant, for reduced insulin secretion during the OGTT (p=0.07).

Conclusions: The ACE I/D polymorphism is associated with whole body insulin sensitivity and with impaired glucose tolerance in our healthy population. These findings confirm potential interactions between the RAS and the glucose metabolism.